Andrew J. Last
CIK 1485088 · View on SEC EDGAR ↗
First SEC filing: April 24, 2019 · Latest: April 24, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 6, 2024 | BIO | S | 3,000 | $329.94 | $989,820 | 7,559 Direct | -28.41% | Disposed | 13.3% (price as of 2026-08-21) |
| Sept. 1, 2021 | BIO | S | 599 | $814.09 | $487,640 | 1,282 Direct | -31.84% | Disposed | -54.1% (price as of 2026-08-21) |
| Sept. 1, 2021 | BIO | S | 651 | $813.15 | $529,361 | 1,881 Direct | -25.71% | Disposed | -54.0% (price as of 2026-08-21) |
| Sept. 1, 2021 | BIO | S | 750 | $812.27 | $609,202 | 2,532 Direct | -22.85% | Disposed | -54.0% (price as of 2026-08-21) |
| Nov. 13, 2017 | PGEN | P | 2,000 | $12.10 | $24,200 | 4,000 Direct | +100.00% | Acquired | -39.7% (price as of 2026-08-21) |
| Aug. 14, 2017 | PGEN | P | 2,000 | $19.99 | $39,980 | 2,000 Direct | — | Acquired | -63.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 6, 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $299.24 | April 29, 2029 | 3,000 | Disposed |
| Sept. 2, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (903) | — | — | 903 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (633) | — | — | 633 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (867) | — | — | 867 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,252) | — | — | 1,252 | Disposed |
| April 29, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,000) | — | — | 1,000 | Disposed |
| March 8, 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (5,891) | $343.76 | March 8, 2034 | 5,891 | Acquired |
| Sept. 2, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (903) | — | — | 903 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (633) | — | — | 633 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (867) | — | — | 867 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (5,008) | — | — | 5,008 | Acquired |
| April 29, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,000) | — | — | 1,000 | Disposed |
| Sept. 2, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (902) | — | — | 902 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (633) | — | — | 633 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3,469) | — | — | 3,469 | Acquired |
| April 29, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,000) | — | — | 1,000 | Disposed |
| Sept. 2, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (902) | — | — | 902 | Disposed |
| Sept. 1, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (2,000) | $299.24 | April 29, 2029 | 2,000 | Disposed |
| Sept. 1, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (2,532) | $814.95 | Sept. 1, 2031 | 2,532 | Acquired |
| Sept. 1, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2,532) | — | — | 2,532 | Acquired |
| April 29, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,000) | — | — | 1,000 | Disposed |
| July 17, 2019 | IMDX | Option to Purchase Common Stock | Common Stock (45,000) | $2.12 | July 16, 2029 | 45,000 | Acquired |
| Aug. 30, 2018 | IMDX | Option to Purchase Common Stock | Common Stock (45,000) | $2.40 | Aug. 29, 2028 | 45,000 | Acquired |
| June 15, 2017 | IMDX | Option to Purchase Common Stock | Common Stock (20,000) | $5.10 | June 14, 2027 | 20,000 | Acquired |
| June 15, 2017 | IMDX | Option to Purchase Common Stock | Common Stock (6,520) | $5.10 | June 14, 2027 | 6,520 | Acquired |
| Aug. 29, 2016 | PGEN | Option to Purchase Common Stock (Right to Buy) | Common Stock (600,000) | $25.47 | Aug. 29, 2026 | 600,000 | Acquired |
| Feb. 16, 2016 | IMDX | Option to Purchase Common Stock | Common Stock (20,000) | $3.06 | Feb. 15, 2026 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BIO
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $660,250 | — | — | — | — | — | $22,044 | $3,270,089 |
| 2019 | $387,019 | $50,000 | $1,496,200 | $412,894 | $335,023 | — | $53,625 | $2,684,761 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $187,564 | — | — | — | — | — | $7,509 | $8,829,793 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.